Micro-X Limited
Research Micro-X Limited (MX1.AX) on Bullrun: market cap AUD 43.64M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMX1.AX
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryMedical Devices
- CurrencyAUD
- Market capAUD 43.64M
- Financial periodFY2025
- RevenueAUD 13.05M
- Revenue growth-14.2%
- Net income-AUD 13.90M
- Free cash flow-AUD 8.69M
- Gross margin79.1%
Valuation Snapshot
latest market cap is AUD 43.64M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | AUD 13.05M | -AUD 13.90M | -AUD 8.69M | 79.1% | -0.02 | AUD 3.24M | AUD 6.53M | AUD 7.55M |
| FY2024 | AUD 15.22M | -AUD 9.77M | -AUD 6.80M | 62.0% | -0.02 | AUD 3.23M | AUD 3.99M | AUD 14.26M |
| FY2023 | AUD 15.01M | -AUD 10.75M | -AUD 11.77M | 76.6% | -0.02 | AUD 5.22M | AUD 4.70M | AUD 17.19M |
| FY2022 | AUD 8.97M | -AUD 17.09M | -AUD 19.22M | 55.7% | -0.04 | AUD 10.30M | AUD 5.31M | AUD 19.29M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | AUD 43.64M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Micro-X Limited
Micro-X Limited engages in the design, development, manufacturing, and commercialization of imaging products for healthcare and security markets through cold cathode X-ray technology in the United States, the Asia-Pacific, Europe, the Middle East, and Africa. The company provides carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components; and electronic switching hardware and reconstruction software products.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Micro-X Limited's market cap?
Micro-X Limited's market capitalization is AUD 43.64M.
What does Micro-X Limited do?
Micro-X Limited engages in the design, development, manufacturing, and commercialization of imaging products for healthcare and security markets through cold cathode X-ray technology in the United States, the Asia-Pacific, Europe, the Middle East, and Africa. The company provides carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components; and electronic switching hardware and reconstruction software products.